Rocket


News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Connect Biopharma Holdings Ltd Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 SC 13G/A Huang James reports a 10.9% stake in Connect Biopharma Holdings Limited
07/14/2023 6-K Quarterly results
06/01/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"INVESTOR CONTACT:"
03/21/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Connect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body Regions March 17, 2023 ePoster and Oral Presentation at American Academy of Dermatology Annual Meeting",
"Connect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient Symptoms March 18, 2023 Late-Breaking Abstract and Oral Presentation at American Academy of Dermatology Annual Meeting • Stage 1 of ongoing 52-week China pivotal AD trial met primary and secondary endpoints • No efficacy plateau at Week 16"
02/14/2023 SC 13G/A Qiming Venture Partners V, L.P. reports a 5.8% stake in Connect Biopharma Holdings Limited
02/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/03/2023 SC 13G Huang James reports a 5.1% stake in Connect Biopharma Holdings Limited
12/30/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"805.427.1372 [email protected] MEDIA"
12/02/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
10/04/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
09/13/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "805.427.1372 [email protected] Corporate Contacts: [email protected] 41"
08/30/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
08/19/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
07/11/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
07/07/2022 EFFECT Form EFFECT - Notice of Effectiveness:
07/01/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/17/2022 F-3/A Form F-3/A - Registration statement by foreign private issuers: [Amend]
06/17/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
06/10/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "2022 Jefferies Global Healthcare Conference Presentation",
"2022 Jefferies Global Healthcare Conference Presentation"
05/20/2022 F-3/A Form F-3/A - Registration statement by foreign private issuers: [Amend]
05/09/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
05/05/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
05/03/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis",
"Corporate presentation"
04/15/2022 F-3 Form F-3 - Registration statement by foreign private issuers:
03/31/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Connect Biopharma Reports Full Year 2021 Financial Results and Provides Business Update"
03/31/2022 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
03/01/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
02/25/2022 SC 13G Wei Zheng reports a 11% stake in Connect Biopharma Holdings Limited
02/25/2022 SC 13G BioFortune Inc reports a 11.1% stake in Connect Biopharma Holdings Limited
02/16/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "SVB Leerink 11th Annual Global Healthcare Conference Presentation",
"SVB Leerink 11th Annual Global Healthcare Conference Presentation"
02/15/2022 SC 13G Advantech Capital II L.P. reports a 8.5% stake in CONNECT BIOPHARMA HOLDINGS LIMITED
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy